跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salubrinal
首页
药物
Salubrinal
Salubrinal
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SALUBRINAL-DRIVEN ATTENUATION OF MALIGNANT PHENOTYPES OF 4T1 BREAST CANCER CELLS
申请人: UNIV INDIANA RES & TECH CORP
优先权: 2014
US
Method of Treating Cancer with a Combination of a Proteasome Inhibitor and Salubrinal
申请人: SCHEWE DENIS M
优先权: 2009
US
Application of small molecule compound Salubrinal in preparation of medicine for treating or improving sarcopenia
申请人: FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV
优先权: 2022
CN
Applications of small molecular compound Salubrinal in drugs for treating or preventing osteoporosis and osteopenia diseases
申请人: ZHANG PING
优先权: 2020
CN
New application of Salubrinal in preparation of medicine for treating aging of bone marrow mesenchymal stem cells
申请人: JIANGSAN UNIV
优先权: 2022
CN
MIXED AMINAL PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
申请人: FRID MICHAEL
优先权: 2011
US
Compound medicinal composition for treating acute lymphocytic leukemia
申请人: UNIV CHINA PHARMA
优先权: 2010
CN
Treatment and prevention of pulmonary injury
申请人: UAB RES FOUND
优先权: 2019
US
WO
3 件公开
药物
反馈